Skip to Content

104 Results Found

  • Communication
  • Open Access
857 Views
14 Pages

Dystonia 3×3: A Training Guideline for Beginners in Botulinum Neurotoxin Treatment of Cervical Dystonia

  • Sebastian Paus,
  • Andreas Funke,
  • Jürgen Hamacher,
  • Bernhard Haslinger and ,
  • Jan Heckelmann,
  • Chi Wang Ip,
  • Wolfgang H. Jost,
  • Anatol Kivi,
  • Stephan Klebe and
  • David T. Weise
  • + 12 authors+ 7 authors

2 September 2026

Cervical dystonia (CD) is a hyperkinetic movement disorder characterized by involuntary muscle contractions leading to abnormal postures of the head and neck. The injection of botulinum neurotoxin type A (BoNT-A) into the muscles involved is the trea...

(This article belongs to the Section Bacterial Toxins)
  • Review
  • Open Access
64 Citations
9,997 Views
15 Pages

Pain Relief in Cervical Dystonia with Botulinum Toxin Treatment

  • Carlos Henrique Ferreira Camargo,
  • Lígia Cattai and
  • Hélio Afonso Ghizoni Teive

23 June 2015

Dystonia is a neurological disorder characterized by intermittent or sustained muscle contractions that cause abnormal, usually repetitive, movements and postures. Dystonic movements can be tremulous and twisting and often follow a pattern. They are...

(This article belongs to the Collection Botulinum Toxins on Human Pain)
  • Review
  • Open Access
27 Citations
10,859 Views
15 Pages

The Role of Ultrasound for the Personalized Botulinum Toxin Treatment of Cervical Dystonia

  • Urban M. Fietzek,
  • Devavrat Nene,
  • Axel Schramm,
  • Silke Appel-Cresswell and ,
  • Zuzana Košutzká,
  • Uwe Walter,
  • Jörg Wissel,
  • Steffen Berweck,
  • Sylvain Chouinard and
  • Tobias Bäumer
  • + 5 authors+ 0 author

20 May 2021

The visualization of the human body has frequently been groundbreaking in medicine. In the last few years, the use of ultrasound (US) imaging has become a well-established procedure for botulinum toxin therapy in people with cervical dystonia (CD). I...

(This article belongs to the Special Issue Botulinum Toxin for the Treatment of Neurological Disorders—Where We Are and Where We Need to Go)
  • Case Report
  • Open Access
5 Citations
3,807 Views
7 Pages

Burst Spinal Cord Stimulation for the Treatment of Cervical Dystonia with Intractable Pain: A Pilot Study

  • Takeshi Shimizu,
  • Tomoyuki Maruo,
  • Shimpei Miura,
  • Yuki Kimoto and ,
  • Yukitaka Ushio,
  • Satoshi Goto and
  • Haruhiko Kishima
  • + 2 authors+ 0 author

7 November 2020

Pain is the most common and disabling non-motor symptom in patients with cervical dystonia. Here, we report four patients with painful cervical dystonia in whom burst spinal cord stimulation (SCS) in the cervical region produced sustained and signifi...

  • Case Report
  • Open Access
13 Citations
7,111 Views
7 Pages

Sensory Trick in a Patient with Cervical Dystonia: Insights from Magnetoencephalography

  • Abhimanyu Mahajan,
  • Andrew Zillgitt,
  • Susan M. Bowyer and
  • Christos Sidiropoulos

Background: The proposed mechanisms for the sensory trick include peripheral sensory feedback to aid in correcting abnormal posture or movement. Case report: A 53-year-old woman with cervical dystonia underwent magnetoencephalography pre- and post-bo...

  • Article
  • Open Access
44 Citations
7,897 Views
15 Pages

23 November 2016

Background: There is emerging evidence that cervical dystonia is a neural network disorder with the cerebellum as a key node. The cerebellum may provide a target for neuromodulation as a therapeutic intervention in cervical dystonia. Objective: This...

(This article belongs to the Special Issue Motor Control and Brain Plasticity)
  • Feature Paper
  • Article
  • Open Access
9 Citations
2,812 Views
15 Pages

Cortico-Subcortical White Matter Bundle Changes in Cervical Dystonia and Blepharospasm

  • Costanza Giannì,
  • Claudia Piervincenzi,
  • Daniele Belvisi,
  • Silvia Tommasin and ,
  • Maria Ilenia De Bartolo,
  • Gina Ferrazzano,
  • Nikolaos Petsas,
  • Giorgio Leodori,
  • Nicoletta Fantoni and
  • Patrizia Pantano
  • + 7 authors+ 2 authors

Dystonia is thought to be a network disorder due to abnormalities in the basal ganglia-thalamo-cortical circuit. We aimed to investigate the white matter (WM) microstructural damage of bundles connecting pre-defined subcortical and cortical regions i...

(This article belongs to the Section Neurobiology and Clinical Neuroscience)
  • Article
  • Open Access
8 Citations
1,989 Views
14 Pages

Is There a “Non-Motor Effect” of Botulinum Toxin Treatment in Cervical Dystonia in Addition to Its Effects on Motor Symptoms?

  • Małgorzata Dudzic,
  • Anna Pieczyńska,
  • Artur Drużdż,
  • Anna Rajewska and
  • Katarzyna Hojan

6 August 2025

The efficacy of botulinum toxin A (BoNT) in alleviating motor symptoms of cervical dystonia (CD) has been well established, and it is the treatment of choice in this disease. Lately, the effect of BoNT on non-motor symptoms (NMS) such as cognitive fu...

(This article belongs to the Special Issue Advances in the Treatment of Movement Disorders with Botulinum Toxins)
  • Article
  • Open Access
6 Citations
4,021 Views
16 Pages

Doses of Botulinum Toxin in Cervical Dystonia: Does Ultrasound Guidance Change Injection Practices?

  • Alexandre Kreisler,
  • Léa Mortain,
  • Kaëlig Watel,
  • Eugénie Mutez and ,
  • Luc Defebvre and
  • Alain Duhamel
  • + 1 author+ 0 author

11 October 2024

Background: Cervical dystonia is widely understood to benefit from botulinum toxin injections. The injection practices may be influenced by specific factors, including the method of injection. Three main guidance methods can be used: palpation of ana...

(This article belongs to the Special Issue Advances in the Treatment of Movement Disorders with Botulinum Toxins)
  • Article
  • Open Access
6 Citations
2,997 Views
13 Pages

Patient Characteristics and Real-World Use of Botulinum Toxins for the Treatment of Cervical Dystonia, Blepharospasm, and Hemifacial Spasm

  • Michael A. Hast,
  • Amanda M. Kong,
  • Shaina Desai,
  • Soo Back and ,
  • Sahar Syed and
  • Jordan Holmes
  • + 1 author+ 0 author

16 August 2024

Movement disorders such as cervical dystonia, blepharospasm, and hemifacial spasm negatively impact the quality of life of people living with these conditions. Botulinum toxin (BoNT) injections are commonly used to treat these disorders. We sought to...

  • Article
  • Open Access
2 Citations
3,037 Views
9 Pages

5 December 2022

Background: Cervical dystonia is a highly disabling hyperkinetic movement disorder with a lot of nonmotor symptoms. One symptom with a high prevalence is depression, which may negatively affect dystonia patients. The aim of the study was to investiga...

(This article belongs to the Special Issue Non-motor Disorders in Parkinson Disease and Other Parkinsonian Syndromes)
  • Systematic Review
  • Open Access
22 Citations
3,081 Views
9 Pages

The Impact of Non-Motor Symptoms on Quality of Life in Cervical Dystonia

  • Raffaela Maione,
  • Caterina Formica,
  • Angelo Quartarone and
  • Viviana Lo Buono

13 July 2023

Cervical dystonia (CD) is characterized by cranial muscle overactivity leading to abnormal intermittent or continuous posturing of the head. Nowadays, the treatment of patients suffering from this condition focuses principally on the motor component...

(This article belongs to the Section Clinical Rehabilitation)
  • Article
  • Open Access
13 Citations
4,717 Views
16 Pages

Quantitative Assessment of Head Tremor in Patients with Essential Tremor and Cervical Dystonia by Using Inertial Sensors

  • Lazar Berbakov,
  • Čarna Jovanović,
  • Marina Svetel,
  • Jelena Vasiljević and ,
  • Goran Dimić and
  • Nenad Radulović
  • + 1 author+ 0 author

30 September 2019

Tremor is most common among the movement disabilities that affect older people, having a prevalence rate of 4.6% in the population older than 65 years. Despite this, distinguishing different types of tremors is clinically challenging, often leading t...

(This article belongs to the Section Intelligent Sensors)
  • Article
  • Open Access
11 Citations
5,842 Views
7 Pages

Cervical Dystonia and Executive Function: A Pilot Magnetoencephalography Study

  • Abhimanyu Mahajan,
  • Andrew Zillgitt,
  • Abdullah Alshammaa,
  • Neepa Patel and ,
  • Christos Sidiropoulos,
  • Peter A. LeWitt and
  • Susan Bowyer
  • + 2 authors+ 0 author

22 August 2018

Background: Cervical dystonia (CD) patients have impaired working memory, processing speed and visual-motor integration ability. We used magnetoencephalography (MEG) to investigate changes in cerebral oscillations in CD patients during an executive f...

  • Article
  • Open Access
8 Citations
6,625 Views
12 Pages

14 July 2021

The real-world use of onabotulinumtoxinA and incobotulinumtoxinA for cervical dystonia and blepharospasm treatment was assessed in two separate retrospective studies using identical protocols (TRUDOSE and TRUDOSE II). The studies were conducted in Me...

(This article belongs to the Section Bacterial Toxins)
  • Review
  • Open Access
10 Citations
4,887 Views
27 Pages

24 July 2020

Cervical dystonia (CD) is a neurological movement disorder characterized by sustained involuntary muscle contractions. First-line therapy for CD is intramuscular injections of botulinum neurotoxin (e.g., abobotulinumtoxinA) into the affected muscles....

(This article belongs to the Special Issue Botulinum Toxin for the Treatment of Neurological Disorders—Where We Are and Where We Need to Go)
  • Article
  • Open Access
8 Citations
7,258 Views
17 Pages

Spectral EMG Changes in Cervical Dystonia Patients and the Influence of Botulinum Toxin Treatment

  • S. W. R. Nijmeijer,
  • E. De Bruijn,
  • R. Verhagen,
  • P. A. Forbes and ,
  • D. J. Kamphuis,
  • R. Happee,
  • M. A. J. Tijssen and
  • J. H. T. M. Koelman
  • + 3 authors+ 0 author

23 August 2017

Botulinum toxin (BoNT) injections in the dystonic muscles is the preferred treatment for Cervical Dystonia (CD), but the proper identification of the dystonic muscles remains a challenge. Previous studies showed decreased 8–14 Hz autospectral power i...

(This article belongs to the Special Issue Muscle Selection for BoNT)
  • Article
  • Open Access
5 Citations
2,298 Views
10 Pages

Memory-Guided Saccades and Non-Motor Symptoms Improve after Botulinum Toxin Therapy in Cervical Dystonia

  • Tihana Gilman Kuric,
  • Zvonimir Popovic,
  • Sara Matosa,
  • Aleksander Sadikov and ,
  • Vida Groznik,
  • Dejan Georgiev,
  • Alessia Gerbasi,
  • Jagoda Kragujevic,
  • Tea Mirosevic Zubonja and
  • Svetlana Tomic
  • + 10 authors+ 5 authors

25 September 2024

Background/Objectives: Cervical dystonia (CD) is a condition characterized by involuntary activity of cervical muscles, which is often accompanied by various non-motor symptoms. Recent studies indicate impaired saccadic eye movements in CD. Local adm...

(This article belongs to the Section Clinical Neurology)
  • Article
  • Open Access
29 Citations
4,955 Views
12 Pages

Effect of Botulinum Toxin on Non-Motor Symptoms in Cervical Dystonia

  • Matteo Costanzo,
  • Daniele Belvisi,
  • Isabella Berardelli,
  • Annalisa Maraone and ,
  • Viola Baione,
  • Gina Ferrazzano,
  • Carolina Cutrona,
  • Giorgio Leodori,
  • Massimo Pasquini and
  • Alfredo Berardelli
  • + 8 authors+ 3 authors

12 September 2021

Patients with cervical dystonia (CD) may display non-motor symptoms, including psychiatric disturbances, pain, and sleep disorders. Intramuscular injection of botulinum toxin type A (BoNT-A) is the most efficacious treatment for motor symptoms in CD,...

  • Article
  • Open Access
2 Citations
3,456 Views
12 Pages

Incidence of Dysphagia and Comorbidities in Patients with Cervical Dystonia, Analyzed by Botulinum Neurotoxin Treatment Exposure

  • Richard L. Barbano,
  • Bahman Jabbari,
  • Marjan Sadeghi,
  • Ahunna Ukah and ,
  • Emma Yue,
  • Kimberly Becker Ifantides,
  • Nuo-Yu Huang and
  • David Swope
  • + 3 authors+ 0 author

19 March 2025

Dysphagia is prevalent in patients with cervical dystonia (CD) and is a potential adverse event in patients treated with botulinum neurotoxin (BoNT) for CD. Real-world studies may provide a better understanding of the incidence and potential risk fac...

(This article belongs to the Special Issue Advances in the Treatment of Movement Disorders with Botulinum Toxins)
  • Article
  • Open Access
17 Citations
3,483 Views
10 Pages

28 September 2022

Aim: The aim of this study was to evaluate the efficacy of ultrasound guidance (US) in the treatment of cervical dystonia (CD) with botulinum neurotoxin type A (BoNT-A) injections in comparison to anatomical landmarks (AL). To date, US is routinely u...

(This article belongs to the Special Issue Botulinum Neurotoxins: From Toxin to Medicine)
  • Article
  • Open Access
11 Citations
4,987 Views
16 Pages

Pain Reduction in Cervical Dystonia Following Treatment with IncobotulinumtoxinA: A Pooled Analysis

  • Alberto Albanese,
  • Jörg Wissel,
  • Wolfgang H. Jost,
  • Anna Castagna and ,
  • Michael Althaus,
  • Georg Comes,
  • Astrid Scheschonka,
  • Matteo Vacchelli and
  • Hyder A. Jinnah
  • + 4 authors+ 0 author

12 May 2023

This analysis pooled pain severity data from four phase 3 and 4 studies of incobotulinumtoxinA (incoBoNT-A) for the treatment of cervical dystonia (CD) in adults. CD-related pain severity was assessed at baseline, each injection visit, and 4 weeks af...

(This article belongs to the Special Issue Botulinum Neurotoxins: From Toxin to Medicine)
  • Article
  • Open Access
14 Citations
7,678 Views
12 Pages

Botulinum Toxin Type A Injection for Cervical Dystonia in Adults with Dyskinetic Cerebral Palsy

  • You Gyoung Yi,
  • Keewon Kim,
  • Youbin Yi,
  • Young-Ah Choi and ,
  • Ja-Ho Leigh and
  • Moon Suk Bang
  • + 1 author+ 0 author

16 May 2018

We aimed to evaluate the efficacy and safety of injecting botulinum toxin A (BoNT-A) into the neck muscles to treat cervical dystonia (CD) in patients with dyskinetic cerebral palsy (CP). This was a randomized, double-blinded, placebo-controlled tria...

(This article belongs to the Special Issue Botulinum Toxin Treatment of Movement Disorders)
  • Article
  • Open Access
487 Views
12 Pages

Two Toxins, One Disorder: Neurophysiological and Clinical Effects in Caput-Type of Cervical Dystonia at Waning and Peak Response Phases of BoNT-A Therapy

  • Artur Drużdż,
  • Małgorzata Dudzic,
  • Igor Bednarski,
  • Anna Sowińska and ,
  • Natalie Górna and
  • Agnieszka Przystańska
  • + 1 author+ 0 author

24 June 2026

Botulinum toxin type A (BoNT-A) is an established treatment for cervical dystonia (CD), but objective neurophysiological markers across the injection cycle and between preparations are not well defined. We assessed afferent conduction (captured by CS...

(This article belongs to the Special Issue Botulinum Toxins: Past Successes and New Goals)
  • Article
  • Open Access
4 Citations
2,303 Views
12 Pages

Sensitization-Associated Symptoms and Neuropathic-like Features in Patients with Cervical Dystonia and Pain

  • Diego de-la-Hoz-López,
  • María L. Cuadrado,
  • Eva López-Valdés,
  • Rocío García-Ramos and ,
  • Fernando Alonso-Frech,
  • Ana Fernández-Revuelta,
  • César Fernández-de-las-Peñas and
  • Víctor Gómez-Mayordomo
  • + 3 authors+ 0 author

7 April 2024

Background: This exploratory study evaluated the presence of sensitization-associated and neuropathic-like symptoms and identified their association with pressure sensitivity, pain, and disability in patients with cervical dystonia (CD). Methods: Thi...

(This article belongs to the Section Clinical Neurology)
  • Case Report
  • Open Access
1,193 Views
8 Pages

Pattern Changes and Recurrent Remissions in Cervical Dystonia: Insights from a Long-Term Treated Case

  • Simone Aloisio,
  • Massimiliano Passaretti,
  • Luca Angelini,
  • Martina De Riggi and ,
  • Francesca Santachiara,
  • Anna Sofia Grandolfo,
  • Daniele Birreci and
  • Matteo Bologna
  • + 3 authors+ 0 author

25 May 2026

Cervical dystonia (CD) is increasingly recognized as a disorder with a dynamic clinical course rather than a fixed phenomenological profile. This report describes the long-term observation of a man with isolated CD followed for nearly 12 years from s...

(This article belongs to the Section Bacterial Toxins)
  • Article
  • Open Access
5 Citations
4,593 Views
15 Pages

Pilot Feasibility Study of a Multi-View Vision Based Scoring Method for Cervical Dystonia

  • Chen Ye,
  • Yuhao Xiao,
  • Ruoyu Li,
  • Hongkai Gu and ,
  • Xinyu Wang,
  • Tianyang Lu and
  • Lingjing Jin
  • + 2 authors+ 0 author

20 June 2022

Abnormal movement of the head and neck is a typical symptom of Cervical Dystonia (CD). Accurate scoring on the severity scale is of great significance for treatment planning. The traditional scoring method is to use a protractor or contact sensors to...

(This article belongs to the Topic Human Movement Analysis)
  • Article
  • Open Access
2 Citations
2,549 Views
12 Pages

Good Clinical Practices for the Management of Cervical Dystonia with BoNT-A: A Delphi-Based Approach from the Italian Expert Group

  • Roberto Eleopra,
  • Marcello Esposito,
  • Anna Rita Bentivoglio,
  • Maria Concetta Altavista and ,
  • Roberto Erro,
  • Patrizia Maria Caglioni and
  • Anna Castagna
  • + 2 authors+ 0 author

2 February 2026

Cervical dystonia (CD) is the most common adult-onset focal dystonia, with heterogeneous clinical presentation and significant functional impairment. Currently, no structured Italian good clinical practice documents specifically addressing CD have be...

  • Review
  • Open Access
7 Citations
6,141 Views
12 Pages

Comparing Injection Methods of Botulinum Toxin A for Cervical Dystonia: A Systematic Review

  • Hristo Shipkov,
  • Petar Uchikov,
  • Abdulrahman Imran,
  • Zain Ul Hassan and ,
  • Ivan Grozdev,
  • Krasimir Kraev,
  • Maria Kraeva,
  • Nina Koleva,
  • Maria Bozhkova and
  • Stanislav Karamitev
  • + 5 authors+ 0 author

6 June 2025

Background: Cervical dystonia (CD) is a chronic neurological disorder characterized by involuntary neck muscle contractions, leading to abnormal head postures, pain, and functional impairment. Botulinum toxin type A (BoNT-A) remains the treatment of...

(This article belongs to the Special Issue Feature Paper in Physiology and Pathology: 2nd Edition)
  • Article
  • Open Access
17 Citations
7,752 Views
8 Pages

Continuation of Long-Term Care for Cervical Dystonia at an Academic Movement Disorders Clinic

  • Chandler E. Gill,
  • Neil D. Manus,
  • Michael W. Pelster,
  • Jason A. Cook and ,
  • Wallace Title,
  • Anna L. Molinari and
  • David Charles
  • + 2 authors+ 0 author

23 April 2013

Patients with cervical dystonia (CD) receive much of their care at university based hospital outpatient clinics. This study aimed to describe the clinical characteristics and treatment experiences of patients who continued care at our university base...

(This article belongs to the Special Issue Clinical Use of Botulinum Toxins)
  • Article
  • Open Access
3 Citations
1,687 Views
16 Pages

Neurophysiological Assessment of F-Wave, M-Wave, and Cutaneous Silent Period in Patients with Caput-Pattern Cervical Dystonia at Waning and Peak Response Phases of Botulinum Toxin Therapy

  • Artur Drużdż,
  • Edyta Leśniewska-Furs,
  • Małgorzata Dudzic,
  • Anna Sowińska and ,
  • Szymon Jurga and
  • Wolfgang H. Jost
  • + 1 author+ 0 author

30 December 2025

While distinguishing between collis and caput patterns in cervical dystonia (CD) has clear clinical and therapeutic relevance, the effects of botulinum toxin type A (BoNT-A) on segmental spinal excitability and inhibitory function in caput-pattern CD...

(This article belongs to the Special Issue Advances in the Treatment of Movement Disorders with Botulinum Toxins)
  • Article
  • Open Access
10 Citations
6,706 Views
10 Pages

Purpose: The pathophysiology of cervical dystonia (CD) is thought to be related to changes in dopamine and serotonin levels in the brain. We performed a double-blind trial with escitalopram (selective serotonin reuptake inhibitor; SSRI) in patients w...

(This article belongs to the Special Issue Dopamine Receptor in Health and Diseases)
  • Study Protocol
  • Open Access
1 Citations
1,910 Views
8 Pages

Efficacy of Segmental Muscle Vibration on Pain Modulation in Patients with Primary Cervical Dystonia Treated with Botulinum Type-A Toxin: A Protocol for a Randomized Controlled Trial

  • Riccardo Buraschi,
  • Paolo Pedersini,
  • Giacomo Redegalli,
  • Rosa Pullara and ,
  • Joel Pollet,
  • Marina Rossi,
  • Massimiliano Gobbo,
  • Sara Gueli and
  • Maurizio Falso
  • + 4 authors+ 0 author

Primary cervical dystonia (PCD), or spasmodic torticollis, is a focal dystonia characterized by involuntary and often painful muscle contractions, leading to abnormal cervical movements and postures. While botulinum toxin injections are the first-lin...

  • Study Protocol
  • Open Access
2 Citations
2,891 Views
18 Pages

Protocol and Demographics of the RELY-CD Study: Assessing Long-Term Clinical Response to Botulinum Neurotoxin in Cervical Dystonia

  • Benjamin Waeschle,
  • John-Ih Lee,
  • Tristan Kölsche,
  • Robin Jansen and ,
  • Marta Banach,
  • Stanislaw Ochudlo,
  • Małgorzata Tyślerowicz,
  • Piotr Sobolewski,
  • Sara Sánchez Valiente and
  • Philipp Albrecht
  • + 14 authors+ 9 authors

5 April 2025

The RELY-CD study investigated the long-term clinical response to botulinum neurotoxin type A in cervical dystonia within a multicenter, real-world setting. This retrospective study focused on patients treated with complex-free (incobotulinumtoxinA)...

(This article belongs to the Special Issue Immunogenicity of Botulinum Toxin)
  • Article
  • Open Access
1,477 Views
16 Pages

20 November 2025

Background/Objectives: Cervical dystonia (CD) is the most common focal dystonia, but nationwide evidence on healthcare use is limited. This study assessed trends in utilization and expenditures in Korea. Methods: Using National Health Insurance Servi...

  • Article
  • Open Access
2 Citations
2,010 Views
12 Pages

30 September 2023

Background: Repetitive intramuscular injections of botulinum neurotoxin type A (BoNT/A) are the treatment of choice in patients with cervical dystonia (CD). As soon as BoNT therapy is initiated, the natural course of CD cannot be observed anymore. Ne...

(This article belongs to the Section Bacterial Toxins)
  • Article
  • Open Access
847 Views
13 Pages

12 April 2026

Patients with cervical dystonia (CD) often believe that disease severity would have progressed beyond the pre-treatment level if botulinum neurotoxin (BoNT) therapy had not been initiated. The aim of the present study was to assess the perceptions of...

(This article belongs to the Special Issue Advances in the Treatment of Movement Disorders with Botulinum Toxins)
  • Article
  • Open Access
1,228 Views
23 Pages

Botulinum Toxin Type A in Spasticity and Cervical Dystonia: Practical Clinical Recommendations from a Mexican Multidisciplinary Panel of Specialist Injectors

  • Jorge Hernández Franco,
  • Salvador J. Santamaría Molina,
  • José J. Zorrilla Sánchez,
  • Jorge Carranza del Río and ,
  • Israel Sánchez Villavicencio,
  • Sofía D. Hernández,
  • Emmanuel Duvignau Dondé,
  • Héctor A. González Usigli,
  • Yadira S. González López and
  • Pedro I. Arias Vázquez
  • + 10 authors+ 5 authors

30 June 2026

Cervical dystonia and spasticity are debilitating neuromuscular disorders that substantially impair quality of life. Botulinum toxin type A (BoNT-A) is a cornerstone therapy; however, heterogeneity in dosing, muscle selection, and guidance techniques...

(This article belongs to the Special Issue Botulinum Toxin in Neuro-Rehabilitation: Expanding Horizons in Spasticity and Beyond)
  • Article
  • Open Access
6 Citations
3,336 Views
16 Pages

Lessons about Botulinum Toxin A Therapy from Cervical Dystonia Patients Drawing the Course of Disease: A Pilot Study

  • Harald Hefter,
  • Isabelle Schomaecker,
  • Max Schomaecker,
  • Beyza Ürer and ,
  • Raphaela Brauns,
  • Dietmar Rosenthal,
  • Philipp Albrecht and
  • Sara Samadzadeh
  • + 3 authors+ 0 author

30 June 2023

Aim of the study: To compare the course of severity of cervical dystonia (CD) before and after long-term botulinum toxin (BoNT) therapy to detect indicators for a good or poor clinical outcome. Patients and Methods: A total of 74 outpatients with idi...

(This article belongs to the Special Issue Immunogenicity of Botulinum Toxin)
  • Article
  • Open Access
5 Citations
3,671 Views
14 Pages

The Impact of the Course of Disease before Botulinum Toxin Therapy on the Course of Treatment and Long-Term Outcome in Cervical Dystonia

  • Harald Hefter,
  • Isabelle Schomaecker,
  • Max Schomaecker,
  • Dietmar Rosenthal and
  • Sara Samadzadeh

16 July 2021

This study analyses the influence of the course of the disease of idiopathic cervical dystonia (CD) before botulinum toxin (BoNT) therapy on long-term outcomes. 74 CD-patients who were treated on a regular basis in the botulinum toxin outpatient depa...

(This article belongs to the Special Issue Botulinum Toxins in Clinical Practice)
  • Article
  • Open Access
2 Citations
5,451 Views
10 Pages

Efficacy Remaining at Time of Requested Re-Treatment for Cervical Dystonia: A Potential New Treatment Paradigm with DaxibotulinumtoxinA

  • Aaron Ellenbogen,
  • Robert A. Hauser,
  • Atul T. Patel,
  • Peter McAllister and ,
  • Todd M. Gross,
  • Rashid Kazerooni,
  • Conor J. Gallagher and
  • David A. Hollander
  • + 3 authors+ 0 author

12 March 2025

The therapeutic efficacy remaining from prior treatments with botulinum toxins (BoNTs) when cervical dystonia (CD) patients prefer to be re-treated has not been well characterized. Here, we assessed the residual therapeutic efficacy of BoNT injection...

  • Case Report
  • Open Access
1,378 Views
13 Pages

Balance, Gait Kinematics, and Fear of Falling After a Four-Month Targeted Training Program in a Patient with Cervical Dystonia: A Case Report

  • Oscar Crisafulli,
  • Marta Sarrocco,
  • Matteo Fortunati,
  • Marco Serra and ,
  • Venere Quintiero and
  • Giuseppe D’Antona
  • + 1 author+ 0 author

In cervical dystonia (CD), balance and gait impairments can compromise daily activities and negatively affect quality of life. However, interventions addressing these deficits remain poorly investigated. A 54-year-old woman with CD, presenting balanc...

  • Article
  • Open Access
1,251 Views
20 Pages

Efficacy and Safety of a Tailored Dosing Strategy with High-Dose IncobotulinumtoxinA at Flexible Injection Intervals for Cervical Dystonia: An Open-Label, Uncontrolled, Single-Arm Study in Japan

  • Akira Tamagawa,
  • Masahiro Horiuchi,
  • Takenori Abe,
  • Shinichi Matsumoto and ,
  • Yohei Mukai,
  • Kunihiko Ikeguchi,
  • Tomoo Mano,
  • Masahito Mihara,
  • Kimiyoshi Arimura and
  • Yusaku Nakamura
  • + 12 authors+ 7 authors

Background: This prospective, multicenter, open-label, single-arm study (jRCT2031230690) evaluated the efficacy and safety of a tailored dosing strategy of incobotulinumtoxinA, including high doses (up to 500 U) and flexible injection intervals (as s...

(This article belongs to the Section Movement Disorders and Neurodegenerative Diseases)
  • Article
  • Open Access
10 Citations
5,821 Views
12 Pages

Dysphagia and Muscle Weakness Secondary to Botulinum Toxin Type A Treatment of Cervical Dystonia: A Drug Class Analysis of Prescribing Information

  • Khashayar Dashtipour,
  • Han S. Lee,
  • Aaron Ellenbogen,
  • Rashid Kazerooni and ,
  • Todd M. Gross,
  • David A. Hollander and
  • Conor J. Gallagher
  • + 2 authors+ 0 author

15 October 2024

The first-line management of cervical dystonia (CD) symptoms is intramuscular injection of botulinum toxin type A (BoNTA). However, a comparison of safety among BoNTAs is difficult because, per regulatory authorities, units of BoNTA activity are not...

(This article belongs to the Section Bacterial Toxins)
  • Article
  • Open Access
7 Citations
3,879 Views
11 Pages

Low-Dose Neubotulinum Toxin A versus Low-Dose Abobotulinum Toxin A Injection for the Treatment of Cervical Dystonia: A Multicenter, 48-Week, Prospective, Double-Blinded, Randomized Crossover Design Study

  • Subsai Kongsaengdao,
  • Arkhom Arayawithchanont,
  • Kanoksri Samintharapanya,
  • Pichai Rojanapitayakorn and ,
  • Benchalak Maneeton and
  • Narong Maneeton
  • + 1 author+ 0 author

1 October 2021

Various types of botulinum toxin (BoNT) have been studied to treat cervical dystonia (CD). Although high-dose BoNT has proven efficacy, it increases the risk of adverse events. For this reason, this study was planned to identify the non-inferiority e...

(This article belongs to the Section Bacterial Toxins)
  • Article
  • Open Access
551 Views
13 Pages

18 June 2026

Background/Objectives: Brain dysfunction and symptoms can be improved with a sensory trick (ST) in more than 80% of patients with cervical dystonia (CD). This study aimed to investigate the functional connectivity (FC) of CD patients with different t...

(This article belongs to the Section Clinical Neurology)
  • Article
  • Open Access
965 Views
15 Pages

19 July 2026

Cervical dystonia (CD) is a focal dystonia typically treated with botulinum toxin type A (BoNT-A), but objective biomarkers of disease state and treatment response are limited. In a prospective controlled observational study with within-subject phase...

(This article belongs to the Special Issue Botulinum Toxins: Past Successes and New Goals)
  • Article
  • Open Access
389 Views
15 Pages

28 August 2026

Pain is a major contributor to disability in cervical dystonia (CD) and may persist despite improvement in abnormal head posture after botulinum toxin treatment. Whether increasing the dose of Neubotulinum toxin type A (Neu-BoNT-A) provides additiona...

(This article belongs to the Special Issue Efficacy of Botulinum Toxin in Orofacial Pain)
  • Article
  • Open Access
1,074 Views
11 Pages

The Impact of OnabotulinumtoxinA on Oral Pain Medication Prescription Fills and Low-Value Care in Patients with Cervical Dystonia in the United States: A Retrospective Claims Analysis

  • Christopher Rhyne,
  • Annaliza Dominguez,
  • Ning Cheng,
  • Shivaji Manthena and ,
  • Krutika Parikh and
  • Bahman Jabbari
  • + 1 author+ 0 author

17 June 2026

(1) Background: While evidence supporting the use of onabotulinumtoxinA in patients with cervical dystonia (CD) is well-established, more evidence is needed to understand if onabotulinumtoxinA treatment can reduce reliance on addictive medication. (2...

(This article belongs to the Section Bacterial Toxins)
  • Article
  • Open Access
6 Citations
2,781 Views
12 Pages

7 January 2022

Background and Objectives: The present study aims to analyze the complex patient/treating physician interaction at onset of botulinum toxin (BoNT) therapy in patients with idiopathic cervical dystonia (CD) and the influence of high initial doses on l...

of 3